JP2015500340A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015500340A5 JP2015500340A5 JP2014547181A JP2014547181A JP2015500340A5 JP 2015500340 A5 JP2015500340 A5 JP 2015500340A5 JP 2014547181 A JP2014547181 A JP 2014547181A JP 2014547181 A JP2014547181 A JP 2014547181A JP 2015500340 A5 JP2015500340 A5 JP 2015500340A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- glutamine
- diverticulosis
- composition according
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 19
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 7
- 206010013554 Diverticulum Diseases 0.000 claims 5
- 150000008540 L-glutamines Chemical class 0.000 claims 4
- 229930182816 L-glutamine Natural products 0.000 claims 3
- 230000037396 body weight Effects 0.000 claims 2
- 239000000835 fiber Substances 0.000 claims 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- 229920001353 Dextrin Polymers 0.000 claims 1
- 241001499733 Plantago asiatica Species 0.000 claims 1
- 235000003421 Plantago ovata Nutrition 0.000 claims 1
- 239000009223 Psyllium Substances 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000007894 caplet Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000007910 chewable tablet Substances 0.000 claims 1
- 229940068682 chewable tablet Drugs 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 229960002900 methylcellulose Drugs 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 229940070687 psyllium Drugs 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 229940075430 wheat dextrin Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161630831P | 2011-12-19 | 2011-12-19 | |
| US61/630,831 | 2011-12-19 | ||
| PCT/US2012/000576 WO2013095681A1 (en) | 2011-12-19 | 2012-12-14 | Methods and compositions for the treatment of diverticulosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015500340A JP2015500340A (ja) | 2015-01-05 |
| JP2015500340A5 true JP2015500340A5 (enExample) | 2015-02-12 |
| JP6060176B2 JP6060176B2 (ja) | 2017-01-11 |
Family
ID=48669319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014547181A Active JP6060176B2 (ja) | 2011-12-19 | 2012-12-14 | 憩室症の治療のための方法及び組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US9616041B2 (enExample) |
| EP (2) | EP3603631B1 (enExample) |
| JP (1) | JP6060176B2 (enExample) |
| KR (4) | KR20180039187A (enExample) |
| CN (1) | CN104114165B (enExample) |
| AU (1) | AU2012355956B2 (enExample) |
| BR (1) | BR112014014765A8 (enExample) |
| DK (1) | DK2793875T3 (enExample) |
| ES (1) | ES2770585T3 (enExample) |
| IN (1) | IN2014KN01255A (enExample) |
| MX (1) | MX351688B (enExample) |
| RU (2) | RU2662917C2 (enExample) |
| WO (1) | WO2013095681A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3603631B1 (en) * | 2011-12-19 | 2023-11-29 | Emmaus Medical, Inc. | Methods and compositions for the treatment of diverticulosis |
| CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
| EP3790545A4 (en) * | 2019-07-17 | 2021-07-28 | Emmaus Medical, Inc. | METHODS AND COMPOSITIONS FOR TREATMENT OF SICKLE CLEANEMIA AND THALASSEMIA |
| US20230053227A1 (en) * | 2021-07-27 | 2023-02-16 | G&S Laboratories, Inc. | Dietary fiber compositions |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0738146B1 (en) * | 1994-01-11 | 2003-05-02 | N.V. Nutricia | Method of treating disorders of the animal or human body by administering amino acids |
| JP2000060487A (ja) * | 1998-08-27 | 2000-02-29 | Kao Corp | 便秘改善剤 |
| US7030092B1 (en) | 2001-08-24 | 2006-04-18 | Small Giant L.L.C. | Ultra-high fiber supplement and method of reducing weight cardiovascular risks and ingested toxins. |
| US20040005304A1 (en) * | 2002-07-08 | 2004-01-08 | Mak Wood, Inc. | Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions |
| US7988989B2 (en) * | 2003-05-09 | 2011-08-02 | Freedom Health, Llc | Nutritional product for enhancing growth and/or strengthening the immune system of equine foals |
| US20050058671A1 (en) * | 2003-05-09 | 2005-03-17 | Bedding Peter M.J. | Dietary supplement and method for treating digestive system-related disorders |
| US8512789B2 (en) * | 2005-11-23 | 2013-08-20 | The Coca-Cola Company | High-potency sweetener composition with dietary fiber and compositions sweetened therewith |
| US20080003265A1 (en) | 2006-06-28 | 2008-01-03 | John Francis Casey | Protein and fiber containing dietary supplement |
| PL2561766T3 (pl) * | 2006-11-07 | 2018-06-29 | The Procter And Gamble Company | Kompozycje zawierające błonnik oraz sposoby ich wytwarzania i stosowania |
| RU2454730C1 (ru) * | 2011-03-15 | 2012-06-27 | Александр Михайлович Пузиков | Способ лечения дивертикулеза в эксперименте |
| EP3603631B1 (en) * | 2011-12-19 | 2023-11-29 | Emmaus Medical, Inc. | Methods and compositions for the treatment of diverticulosis |
-
2012
- 2012-12-14 EP EP19199336.9A patent/EP3603631B1/en active Active
- 2012-12-14 RU RU2014123433A patent/RU2662917C2/ru active
- 2012-12-14 KR KR1020187009799A patent/KR20180039187A/ko not_active Ceased
- 2012-12-14 RU RU2018126834A patent/RU2733396C2/ru active
- 2012-12-14 MX MX2014007382A patent/MX351688B/es active IP Right Grant
- 2012-12-14 CN CN201280062802.4A patent/CN104114165B/zh active Active
- 2012-12-14 US US13/694,592 patent/US9616041B2/en active Active
- 2012-12-14 WO PCT/US2012/000576 patent/WO2013095681A1/en not_active Ceased
- 2012-12-14 ES ES12860587T patent/ES2770585T3/es active Active
- 2012-12-14 EP EP12860587.0A patent/EP2793875B1/en active Active
- 2012-12-14 KR KR1020177008405A patent/KR101848722B1/ko active Active
- 2012-12-14 AU AU2012355956A patent/AU2012355956B2/en active Active
- 2012-12-14 BR BR112014014765A patent/BR112014014765A8/pt not_active Application Discontinuation
- 2012-12-14 KR KR1020177020002A patent/KR20170087531A/ko not_active Ceased
- 2012-12-14 KR KR1020147016785A patent/KR20140103281A/ko not_active Ceased
- 2012-12-14 DK DK12860587.0T patent/DK2793875T3/da active
- 2012-12-14 JP JP2014547181A patent/JP6060176B2/ja active Active
-
2014
- 2014-06-10 IN IN1255/KOLNP/2014A patent/IN2014KN01255A/en unknown
-
2017
- 2017-02-10 US US15/530,630 patent/US10258586B2/en active Active
-
2019
- 2019-02-11 US US16/501,039 patent/US11304918B2/en active Active
-
2022
- 2022-03-09 US US17/803,158 patent/US20220202758A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012255026A5 (enExample) | ||
| HRP20240168T1 (hr) | Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije | |
| JP2012532093A5 (enExample) | ||
| MD4736B1 (ro) | Compus policiclic de carbamoilpiridonă şi utilizarea farmaceutică a acestuia | |
| JP2011522896A5 (enExample) | ||
| MY173877A (en) | Branched 3-phenylpropionic acid derivatives and the use thereof | |
| FI3435996T3 (fi) | Elafibranori käytettäväksi primaarisen biliaarisen kolangiitin hoidossa | |
| PH12015502539B1 (en) | Cenicriviroc compositions and methods of making and using the same | |
| HRP20180237T4 (hr) | Metode za liječenje hcv-a | |
| CA2894892A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| JP2009537554A5 (enExample) | ||
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| DOP2015000012A (es) | Acidos 5-aminotetrahidroquinolin-2-carboxilicos novedosos y su uso | |
| JP2016147915A5 (enExample) | ||
| JP2015057451A5 (enExample) | ||
| IL295418B1 (en) | Beta-d-2'-deoxy-2' alpha-fluoro-2'-bata-c-modified-2-different-n6-purine modified nucleotides for the treatment of hepatitis c virus | |
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| CL2013000677A1 (es) | Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn. | |
| JP2013166781A5 (enExample) | ||
| JP2015500340A5 (enExample) | ||
| HK1214519A1 (zh) | 雙用途硫酸鹽口服藥物組合物片劑及其使用方法 | |
| JP2014062109A5 (enExample) | ||
| JP2014533256A5 (enExample) | ||
| JP2012525422A5 (enExample) | ||
| ZA201404068B (en) | The use of silver(i) complexes as active pharmaceutical ingredients (api's) iincluding anticancer agents |